Savara (SVRA) Enterprise Value (2010 - 2026)
Savara's (SVRA) quarterly Enterprise Value came in at -$202.8 million in Q1 2026, down 17.54% year-on-year from -$245.9 million in Q1 2025, and up 13.96% on a QoQ basis from -$235.7 million in Q4 2025.
Savara (SVRA) Enterprise Value (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Enterprise Value data on file, last reported at -$202.8 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 17.54% year-over-year to -$202.8 million in Q1 2026; TTM through Mar 2026 was -$202.8 million, a 17.54% decrease from a year earlier, with the FY2025 full-year figure at -$235.7 million, down 20.06% from the prior year.
- Enterprise Value for Q1 2026 stood at -$202.8 million, up from -$235.7 million in the prior quarter.
- Over the last five years, Enterprise Value for SVRA reached as high as -$105.1 million in Q2 2023 and fell as low as -$235.7 million in Q4 2025.
- Historically, Enterprise Value has averaged -$156.9 million across 5 years, with a median of -$146.4 million in 2025.
- Across the five-year window, Enterprise Value slumped 30.39% in 2024 and surged 43.32% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$125.9 million in 2022, then retreated by 28.95% to -$162.3 million in 2023, then dropped by 20.95% to -$196.3 million in 2024, then retreated by 20.06% to -$235.7 million in 2025, then increased by 13.96% to -$202.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$202.8 million in Q1 2026, -$235.7 million in Q4 2025, and -$124.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | -202.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202.80 Mn |
| Dec 31, 2025 | -235.70 Mn |
| Sep 30, 2025 | -124.39 Mn |
| Jun 30, 2025 | -146.40 Mn |
| Mar 31, 2025 | -172.54 Mn |
| Dec 31, 2024 | -196.33 Mn |
| Sep 30, 2024 | -219.44 Mn |
| Jun 30, 2024 | -121.60 Mn |
| Mar 31, 2024 | -143.10 Mn |
| Dec 31, 2023 | -162.32 Mn |
| Sep 30, 2023 | -168.30 Mn |
| Jun 30, 2023 | -105.13 Mn |
| Mar 31, 2023 | -114.79 Mn |
| Dec 31, 2022 | -125.88 Mn |
| Sep 30, 2022 | -134.00 Mn |
| Jun 30, 2022 | -142.44 Mn |
| Mar 31, 2022 | -151.83 Mn |
| Dec 31, 2021 | -161.17 Mn |
| Sep 30, 2021 | -170.81 Mn |
| Jun 30, 2021 | -180.67 Mn |